Chikungunya Vaccine Deaths: Underrepresented Trials Highlight Risks | Sociedad
Chikungunya Vaccine Concerns: What’s Next for Vaccine Safety and Clinical Trials? The recent recommendation by the European Medicines Agency (EMA) to restrict the use of the Ixchiq chikungunya vaccine in individuals over 65 has raised important questions about vaccine safety and the representation of diverse populations in clinical trials. This decision, prompted by reported serious … Read more